eXoZymes, Inc. (EXOZ) is a Healthcare · Biotechnology company listed on NASDAQ. Price $6.02 (-2.75%), Market cap $0.08B, 52-week low–high $7.09 ~ $16.50.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Financial statements, price targets, institutional (13F) holdings and related news for eXoZymes, Inc. are updated in real time on BlackAll Trade.
eXoZymes, Inc. trades at $6.02 (-2.75%). Real-time quotes and charts are available on BlackAll Trade.
eXoZymes, Inc. has a market cap of about $0.08B.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The compan